MetLife Investment Management’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Hold |
49,941
| – | – | 0.01% | 1286 |
|
|
2025
Q1 | $818K | Sell |
49,941
-674
| -1% | -$11K | ﹤0.01% | 1456 |
|
|
2024
Q4 | $1.3M | Buy |
50,615
+3,257
| +7% | +$83.7K | 0.01% | 1287 |
|
|
2024
Q3 | $1.5M | Buy |
47,358
+4,164
| +10% | +$132K | 0.01% | 1173 |
|
|
2024
Q2 | $1.52M | Buy |
43,194
+9,574
| +28% | +$336K | 0.01% | 1114 |
|
|
2024
Q1 | $1.48M | Buy |
33,620
+1,988
| +6% | +$87.2K | 0.01% | 1091 |
|
|
2023
Q4 | $1.13M | Buy |
31,632
+2,989
| +10% | +$106K | 0.01% | 1229 |
|
|
2023
Q3 | $773K | Hold |
28,643
| – | – | 0.01% | 1372 |
|
|
2023
Q2 | $673K | Buy |
28,643
+5,385
| +23% | +$127K | ﹤0.01% | 1501 |
|
|
2023
Q1 | $319K | Hold |
23,258
| – | – | ﹤0.01% | 1916 |
|
|
2022
Q4 | $423K | Buy |
23,258
+5,987
| +35% | +$109K | ﹤0.01% | 1747 |
|
|
2022
Q3 | $258K | Hold |
17,271
| – | – | ﹤0.01% | 2125 |
|
|
2022
Q2 | $238K | Hold |
17,271
| – | – | ﹤0.01% | 2190 |
|
|
2022
Q1 | $193K | Buy |
17,271
+6,374
| +58% | +$71.3K | ﹤0.01% | 2370 |
|
|
2021
Q4 | $258K | Hold |
10,897
| – | – | ﹤0.01% | 1900 |
|
|
2021
Q3 | $278K | Hold |
10,897
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q2 | $229K | Buy |
10,897
+3,171
| +41% | +$66.6K | ﹤0.01% | 2077 |
|
|
2021
Q1 | $182K | Buy |
+7,726
| New | +$182K | ﹤0.01% | 2105 |
|